Bajaj Finserv Healthcare Fund
The fund maintains a heavily concentrated pharma-centric positioning, with two-thirds of assets in pharmaceutical stocks and a top-10 cluster commanding nearly 60 percent of the portfolio. The addition of Senores Pharmaceuticals signals the manager is selectively hunting for undervalued or emerging plays within the sector, while the reduced cash position suggests conviction in pharmaceutical valuations despite near-term market pressures. This remains a pure-play bet on India's drug manufacturing resilience and domestic healthcare demand, with minimal diversification cushion.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Regular Growth | ₹10.3720 | +8.85% | +12.52% | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Senores Pharmaceuticals Limited | 0.84% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Divi's Laboratories Limited INE361B01024 | 9.10% |
| 2 | Sun Pharmaceutical Industries Limited INE044A01036 | 9.00% |
| 3 | Aurobindo Pharma Limited INE406A01037 | 6.57% |
| 4 | Apollo Hospitals Enterprise Limited INE437A01024 | 6.46% |
| 5 | Piramal Pharma Limited INE0DK501011 | 6.27% |
| 6 | Torrent Pharmaceuticals Limited INE685A01028 | 5.13% |
| 7 | Rubicon Research Limited INE506V01022 | 4.48% |
| 8 | Emcure Pharmaceuticals Limited INE168P01015 | 4.26% |
| 9 | Neuland Laboratories Limited INE794A01010 | 3.96% |
| 10 | Max Healthcare Institute Limited INE027H01010 | 3.90% |
| 11 | Fortis Healthcare Limited INE061F01013 | 3.43% |
| 12 | Zydus Wellness Limited INE768C01028 | 2.73% |
| 13 | IPCA Laboratories Limited INE571A01038 | 2.39% |
| 14 | Vijaya Diagnostic Centre Limited INE043W01024 | 2.16% |
| 15 | Navin Fluorine International Limited INE048G01026 | 2.11% |
| 16 | Glenmark Pharmaceuticals Limited INE935A01035 | 2.07% |
| 17 | Sanofi Consumer Healthcare India Limited INE0UOS01011 | 2.04% |
| 18 | Shaily Engineering Plastics Limited INE151G01028 | 1.94% |
| 19 | GlaxoSmithKline Pharmaceuticals Limited INE159A01016 | 1.72% |
| 20 | Laurus Labs Limited INE947Q01028 | 1.70% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does Bajaj Finserv Healthcare Fund hold?
Bajaj Finserv Healthcare Fund holds 35 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 37.40% of NAV.
What is the largest holding in Bajaj Finserv Healthcare Fund?
The largest position in Bajaj Finserv Healthcare Fund is Divi's Laboratories Limited, accounting for 9.10% of NAV in the Pharmaceuticals & Biotechnology sector.
Is Bajaj Finserv Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.395, Bajaj Finserv Healthcare Fund is well-diversified. The HHI concentration index is 45,987 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 37.40% of the portfolio.
What is the market cap allocation of Bajaj Finserv Healthcare Fund?
Based on SEBI's AMFI classification, Bajaj Finserv Healthcare Fund's equity portfolio is split as: Large Cap: 35.24%, Mid Cap: 21.96%, Small Cap: 39.51%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does Bajaj Finserv Healthcare Fund invest in most?
Bajaj Finserv Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (66.46%), Healthcare Services (18.47%), nan (3.29%). The fund is invested across 9 sectors in total.
How actively managed is Bajaj Finserv Healthcare Fund compared to other Sectoral / Thematic funds?
Bajaj Finserv Healthcare Fund has an Active Share of 90.76%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in Bajaj Finserv Healthcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, Bajaj Finserv Healthcare Fund added 1 new stock (including Senores Pharmaceuticals Limited). Total holding count increased from 35 to 36 stocks.